Hosted on MSN11mon
Liver fibrosis, non-parenchymal cells and the promise of exosome therapy
Non-parenchymal cells like hepatic stellate cells (HSCs), Kupffer cells (KCs), and liver sinusoidal endothelial cells (LSECs) play a key role in fibrosis development. These cells are involved in ...
Business Wire11d
Lineage Initiates Clinical Study of OPC1 for Spinal Cord Injury
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...
Hosted on MSN10d
Lineage begins study of OPC1 delivering device for spinal cord injury treatment
An allogeneic stem cell-derived transplant, OPC1 helps restore or increase the functional activity in SCI patients. It is tailored to replace the spinal cord cells that are either ...
Too Old to Operate11d
Pulmonary Function Subgroups and Respiratory Risks in Preterm Infants
The following is a summary of “Physiologic Pulmonary Phenotyping of Infants Born Preterm and Post-Discharge Respiratory ...
emjreviews.com7d
Hormonal Influence on Background Parenchymal Enhancement in CEM
Hormonal factors significantly influence the degree of background parenchymal enhancement (BPE) in CEM, study finds. Read ...
Pharmabiz9d
Lineage Cell Therapeutics initiates DOSED clinical study of OPC1 for spinal cord injury
Lineage Cell Therapeutics initiates DOSED clinical study of OPC1 for spinal cord injury: Carlsbad, California Thursday, February 13, 2025, 14:00 Hrs [IST] Lineage Cell Therapeutic ...